Cargando…
Investigating the Anticancer Activity of G-Rh1 Using In Silico and In Vitro Studies (A549 Lung Cancer Cells)
Ginsenoside Rh1 (G-Rh1), a possible bioactive substance isolated from the Korean Panax ginseng Meyer, has a wide range of pharmacological effects. In this study, we have investigated the anticancer efficacy of G-Rh1 via in silico and in vitro methodologies. This study mainly focuses on the two metas...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890317/ https://www.ncbi.nlm.nih.gov/pubmed/36500403 http://dx.doi.org/10.3390/molecules27238311 |
_version_ | 1784880923669430272 |
---|---|
author | Nahar, Jinnatun Boopathi, Vinothini Murugesan, Mohanapriya Rupa, Esrat Jahan Yang, Deok Chun Kang, Se Chan Mathiyalagan, Ramya |
author_facet | Nahar, Jinnatun Boopathi, Vinothini Murugesan, Mohanapriya Rupa, Esrat Jahan Yang, Deok Chun Kang, Se Chan Mathiyalagan, Ramya |
author_sort | Nahar, Jinnatun |
collection | PubMed |
description | Ginsenoside Rh1 (G-Rh1), a possible bioactive substance isolated from the Korean Panax ginseng Meyer, has a wide range of pharmacological effects. In this study, we have investigated the anticancer efficacy of G-Rh1 via in silico and in vitro methodologies. This study mainly focuses on the two metastatic regulators, Rho-associated protein kinase 1 (ROCK1) and RhoA, along with other standard apoptosis regulators. The ROCK1 protein is a member of the active serine/threonine kinase family that is crucial for many biological processes, including cell division, differentiation, and death, as well as many cellular processes and muscle contraction. The abnormal activation of ROCK1 kinase causes several disorders, whereas numerous studies have also shown that RhoA is expressed highly in various cancers, including colon, lung, ovarian, gastric, and liver malignancies. Hence, inhibiting both ROCK1 and RhoA will be promising in preventing metastasis. Therefore, the molecular level interaction of G-Rh1 with the ROCK1 and RhoA active site residues from the preliminary screening clearly shows its inhibitory potential. Molecular dynamics simulation and principal component analysis give essential insights for comprehending the conformational changes that result from G-Rh1 binding to ROCK1 and RhoA. Further, MTT assay was employed to examine the potential cytotoxicity in vitro against human lung cancer cells (A549) and Raw 264.7 Murine macrophage cells. Thus, G-Rh1 showed significant cytotoxicity against human lung adenocarcinoma (A549) at 100 µg/mL. In addition, we observed an elevated level of reactive oxygen species (ROS) generation, perhaps promoting cancer cell toxicity. Additionally, G-Rh1 suppressed the mRNA expression of RhoA, ROCK1, MMP1, and MMP9 in cancer cell. Accordingly, G-Rh1 upregulated the p53, Bax, Caspase 3, caspase 9 while Bcl2 is downregulated intrinsic pathway. The findings from our study propose that the anticancer activity of G-Rh1 may be related to the induction of apoptosis by the RhoA/ROCK1 signaling pathway. As a result, this study evaluated the functional drug-like compound G-Rh1 from Panax ginseng in preventing and treating lung cancer adenocarcinoma via regulating metastasis and apoptosis. |
format | Online Article Text |
id | pubmed-9890317 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98903172023-02-02 Investigating the Anticancer Activity of G-Rh1 Using In Silico and In Vitro Studies (A549 Lung Cancer Cells) Nahar, Jinnatun Boopathi, Vinothini Murugesan, Mohanapriya Rupa, Esrat Jahan Yang, Deok Chun Kang, Se Chan Mathiyalagan, Ramya Molecules Article Ginsenoside Rh1 (G-Rh1), a possible bioactive substance isolated from the Korean Panax ginseng Meyer, has a wide range of pharmacological effects. In this study, we have investigated the anticancer efficacy of G-Rh1 via in silico and in vitro methodologies. This study mainly focuses on the two metastatic regulators, Rho-associated protein kinase 1 (ROCK1) and RhoA, along with other standard apoptosis regulators. The ROCK1 protein is a member of the active serine/threonine kinase family that is crucial for many biological processes, including cell division, differentiation, and death, as well as many cellular processes and muscle contraction. The abnormal activation of ROCK1 kinase causes several disorders, whereas numerous studies have also shown that RhoA is expressed highly in various cancers, including colon, lung, ovarian, gastric, and liver malignancies. Hence, inhibiting both ROCK1 and RhoA will be promising in preventing metastasis. Therefore, the molecular level interaction of G-Rh1 with the ROCK1 and RhoA active site residues from the preliminary screening clearly shows its inhibitory potential. Molecular dynamics simulation and principal component analysis give essential insights for comprehending the conformational changes that result from G-Rh1 binding to ROCK1 and RhoA. Further, MTT assay was employed to examine the potential cytotoxicity in vitro against human lung cancer cells (A549) and Raw 264.7 Murine macrophage cells. Thus, G-Rh1 showed significant cytotoxicity against human lung adenocarcinoma (A549) at 100 µg/mL. In addition, we observed an elevated level of reactive oxygen species (ROS) generation, perhaps promoting cancer cell toxicity. Additionally, G-Rh1 suppressed the mRNA expression of RhoA, ROCK1, MMP1, and MMP9 in cancer cell. Accordingly, G-Rh1 upregulated the p53, Bax, Caspase 3, caspase 9 while Bcl2 is downregulated intrinsic pathway. The findings from our study propose that the anticancer activity of G-Rh1 may be related to the induction of apoptosis by the RhoA/ROCK1 signaling pathway. As a result, this study evaluated the functional drug-like compound G-Rh1 from Panax ginseng in preventing and treating lung cancer adenocarcinoma via regulating metastasis and apoptosis. MDPI 2022-11-28 /pmc/articles/PMC9890317/ /pubmed/36500403 http://dx.doi.org/10.3390/molecules27238311 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nahar, Jinnatun Boopathi, Vinothini Murugesan, Mohanapriya Rupa, Esrat Jahan Yang, Deok Chun Kang, Se Chan Mathiyalagan, Ramya Investigating the Anticancer Activity of G-Rh1 Using In Silico and In Vitro Studies (A549 Lung Cancer Cells) |
title | Investigating the Anticancer Activity of G-Rh1 Using In Silico and In Vitro Studies (A549 Lung Cancer Cells) |
title_full | Investigating the Anticancer Activity of G-Rh1 Using In Silico and In Vitro Studies (A549 Lung Cancer Cells) |
title_fullStr | Investigating the Anticancer Activity of G-Rh1 Using In Silico and In Vitro Studies (A549 Lung Cancer Cells) |
title_full_unstemmed | Investigating the Anticancer Activity of G-Rh1 Using In Silico and In Vitro Studies (A549 Lung Cancer Cells) |
title_short | Investigating the Anticancer Activity of G-Rh1 Using In Silico and In Vitro Studies (A549 Lung Cancer Cells) |
title_sort | investigating the anticancer activity of g-rh1 using in silico and in vitro studies (a549 lung cancer cells) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890317/ https://www.ncbi.nlm.nih.gov/pubmed/36500403 http://dx.doi.org/10.3390/molecules27238311 |
work_keys_str_mv | AT naharjinnatun investigatingtheanticanceractivityofgrh1usinginsilicoandinvitrostudiesa549lungcancercells AT boopathivinothini investigatingtheanticanceractivityofgrh1usinginsilicoandinvitrostudiesa549lungcancercells AT murugesanmohanapriya investigatingtheanticanceractivityofgrh1usinginsilicoandinvitrostudiesa549lungcancercells AT rupaesratjahan investigatingtheanticanceractivityofgrh1usinginsilicoandinvitrostudiesa549lungcancercells AT yangdeokchun investigatingtheanticanceractivityofgrh1usinginsilicoandinvitrostudiesa549lungcancercells AT kangsechan investigatingtheanticanceractivityofgrh1usinginsilicoandinvitrostudiesa549lungcancercells AT mathiyalaganramya investigatingtheanticanceractivityofgrh1usinginsilicoandinvitrostudiesa549lungcancercells |